{"gene":"SYN1","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2011,"finding":"SYN1 D-domain mutations (A51G, A550T, T567A, Q555X) found in autism/epilepsy patients fail to rescue impaired synaptic vesicle pool size and trafficking in SynI knockout neurons; wild-type human SynI fully reverts the KO phenotype. The Q555X nonsense mutation additionally impairs MAPK/Erk phosphorylation of SynI and disrupts neurite outgrowth, while A550T and T567A missense mutants show impaired targeting to nerve terminals.","method":"Expression of human WT and mutant SYN1 in SynI KO neurons (lentiviral transduction), synaptic vesicle pool size/trafficking assays, phosphorylation assays, immunocytochemistry for nerve terminal targeting, neurite outgrowth assays","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal functional assays (vesicle trafficking, phosphorylation, targeting, neurite outgrowth) in a defined KO rescue system; multiple mutants tested","pmids":["21441247"],"is_preprint":false},{"year":2013,"finding":"The epileptogenic Q555X SYN1 mutation causes a parallel decrease in the synaptic vesicle readily releasable pool in inhibitory synapses and reduced release probability in excitatory synapses, leading to reduced synchronous release. It also increases asynchronous release (especially in excitatory synapses), larger facilitation and post-tetanic potentiation in excitatory synapses, stronger depression in inhibitory synapses, and overall network hyperexcitability.","method":"Patch-clamp electrophysiology, electron microscopy, multi-electrode array recordings in SynI KO hippocampal neurons expressing WT or Q555X human SynI via lentiviral transduction","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, EM, MEA) in defined KO rescue system, mechanistic dissection of excitatory vs. inhibitory synapses","pmids":["23406870"],"is_preprint":false},{"year":2017,"finding":"The SYN1 missense mutation S79W (located in the B-domain involved in recognition of highly curved membranes) causes aberrant accumulation of small clear vesicles in the soma, increased clustering of synaptic vesicles at presynaptic terminals, increased frequency of excitatory spontaneous release events, and strongly reduced mobility of synaptic vesicles when expressed in Syn1 KO hippocampal neurons.","method":"Expression of human S79W SynI in Syn1 KO hippocampal neurons, immunocytochemistry, electrophysiology (spontaneous release), live imaging of synaptic vesicle mobility","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ICC, electrophysiology, live imaging) in defined KO rescue system with mechanistic domain-level interpretation","pmids":["28973667"],"is_preprint":false},{"year":2012,"finding":"SYN1 gene transcription is activated by the transcription factor Sp1 binding to conserved GC-box cis-sites in the SYN1 promoter; REST directly inhibits Sp1-mediated SYN1 transcription. Upon neuronal differentiation, decreased REST levels result in increased Sp1 stability on the promoter and increased SYN1 transcription. CpG methylation of Sp1 cis-sites provides an additional level of SYN1 transcriptional repression.","method":"Chromatin immunoprecipitation (ChIP), luciferase reporter assays, Sp1/REST overexpression and knockdown functional assays in Neuro2a cells, methylation analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal ChIP, reporter assays, and functional KD/OE with multiple orthogonal methods establishing mechanism of SYN1 promoter regulation","pmids":["23250796"],"is_preprint":false},{"year":2021,"finding":"Cdk5 is a negative regulator of SYN1 phosphorylation at Ser-553; upregulation of Cdk5 (via the Calpain-p25 pathway after microwave exposure) decreases p-SYN1(Ser-553) levels, which in turn reduces GABA release, suggesting that Ser-553 phosphorylation of SYN1 by Cdk5 controls vesicular anchoring and inhibitory neurotransmitter release.","method":"In vivo (rat) and in vitro experiments with Cdk5 inhibitors/activators, western blotting for p-SYN1 (Ser-553), GABA release measurements, MEK inhibitor controls","journal":"Current issues in molecular biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — in vivo and in vitro inhibitor studies with functional neurotransmitter readout; single lab but two experimental systems (in vivo and in vitro)","pmids":["35723394"],"is_preprint":false},{"year":2024,"finding":"SP1 binds to the SYN1 promoter region and positively regulates SYN1 expression; SP1-mediated upregulation of SYN1 contributes to hemin-induced neuronal damage (apoptosis, inflammation, oxidative stress) in PC12 cells, and SYN1 knockdown ameliorates blood-brain barrier disruption and brain injury in ICH rat models.","method":"JASPAR database prediction and validation by ChIP and luciferase reporter assays for SP1-SYN1 promoter binding; si-SYN1 and SP1 overexpression in PC12 cells; LDH, CCK-8, TUNEL, western blotting; intracerebroventricular si-SYN1 in ICH rats with neurobehavioral/brain edema/Evans blue assays","journal":"Pathology, research and practice","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — ChIP and luciferase validate SP1 binding to SYN1 promoter; functional loss-of-function in vitro and in vivo; single lab","pmids":["39561537"],"is_preprint":false},{"year":2014,"finding":"Foxp2 transcription factor binds to the SYN1 promoter at -400/-600 bp upstream of the transcription start site and positively regulates SYN1 expression; miR-134-5p suppresses Foxp2 (via direct targeting of Foxp2 mRNA, validated by dual luciferase assay), leading to loss of SYN1 expression and synaptic protein reduction in a vascular dementia rat model.","method":"ChIP-qPCR for Foxp2 binding to SYN1 promoter; dual luciferase assay confirming miR-134-5p targeting of Foxp2 mRNA; western blotting; miR-134-5p antagomir intracerebroventricular injection in VD rats","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase reporter validate transcriptional mechanism; in vivo rescue experiment; single lab","pmids":["31545395"],"is_preprint":false}],"current_model":"SYN1 encodes Synapsin I, a presynaptic phosphoprotein that regulates synaptic vesicle pool size, vesicle clustering, mobility, and both synchronous and asynchronous neurotransmitter release in excitatory and inhibitory synapses; its transcription is activated by Sp1 and Foxp2 and repressed by REST and CpG methylation; phosphorylation at Ser-553 (negatively regulated by Cdk5) controls vesicular anchoring and GABA release; and loss-of-function or missense mutations in its proline-rich D-domain or B-domain cause distinct impairments in vesicle trafficking and synaptic transmission underlying epilepsy, autism, and intellectual disability."},"narrative":{"mechanistic_narrative":"SYN1 encodes Synapsin I, a presynaptic phosphoprotein that governs the size, clustering, and mobility of the synaptic vesicle pool and thereby shapes both synchronous and asynchronous neurotransmitter release at excitatory and inhibitory terminals [PMID:21441247, PMID:23406870, PMID:28973667]. Disease-associated mutations dissect these functions by domain: D-domain mutations (A51G, A550T, T567A, Q555X) found in autism/epilepsy patients fail to rescue vesicle pool size and trafficking defects in Syn1 knockout neurons, with the Q555X nonsense allele additionally abolishing MAPK/Erk phosphorylation and disrupting neurite outgrowth, and A550T/T567A impairing targeting to nerve terminals [PMID:21441247]. Q555X produces a coherent network phenotype—reduced readily releasable pool and release probability driving diminished synchronous release alongside elevated asynchronous release, altered short-term plasticity, and overall hyperexcitability [PMID:23406870]—while the B-domain S79W mutation, in a region recognizing curved membranes, causes somatic accumulation of clear vesicles, excess vesicle clustering, and strongly reduced vesicle mobility [PMID:28973667]. Vesicular anchoring and GABA release are tuned by phosphorylation at Ser-553, which is negatively regulated by Cdk5 [PMID:35723394]. SYN1 transcription is controlled by Sp1/SP1 binding to GC-box promoter sites and by Foxp2, with repression imposed by REST and CpG methylation of the Sp1 sites [PMID:23250796, PMID:39561537, PMID:31545395]. These regulatory and trafficking activities place Synapsin I at the center of presynaptic vesicle dynamics underlying epilepsy, autism, and intellectual disability [PMID:21441247, PMID:23406870].","teleology":[{"year":2011,"claim":"Establishing whether patient SYN1 D-domain variants are functionally pathogenic, this work showed they fail to restore vesicle pool and trafficking in a KO rescue system where wild-type SynI fully reverts the phenotype, linking specific mutations to defined cell-biological defects.","evidence":"Lentiviral expression of human WT and mutant SYN1 in SynI KO neurons with vesicle trafficking, phosphorylation, terminal targeting, and neurite outgrowth assays","pmids":["21441247"],"confidence":"High","gaps":["Does not resolve how D-domain loss mechanistically uncouples vesicle anchoring from MAPK/Erk phosphorylation","Targeting defect of A550T/T567A not traced to a binding partner"]},{"year":2013,"claim":"To determine how the Q555X mutation produces epilepsy, this work dissected its opposing effects on excitatory versus inhibitory synapses, establishing that imbalanced synchronous/asynchronous release generates network hyperexcitability.","evidence":"Patch-clamp electrophysiology, electron microscopy, and multi-electrode array recordings in SynI KO neurons expressing WT or Q555X SynI","pmids":["23406870"],"confidence":"High","gaps":["Molecular basis for the excitatory-vs-inhibitory divergence not defined","Does not establish how loss of phosphorylation translates to altered release probability"]},{"year":2017,"claim":"Probing the B-domain's role in membrane curvature recognition, the S79W mutation was shown to disrupt vesicle mobility and clustering and to cause somatic vesicle accumulation, linking this domain to vesicle dispersion and trafficking distinct from D-domain defects.","evidence":"Expression of human S79W SynI in Syn1 KO neurons with immunocytochemistry, electrophysiology, and live imaging of vesicle mobility","pmids":["28973667"],"confidence":"High","gaps":["Direct demonstration of altered curved-membrane binding by S79W not shown","Mechanism connecting reduced mobility to increased spontaneous excitatory events unresolved"]},{"year":2012,"claim":"Addressing how SYN1 expression is controlled during neuronal differentiation, this work established a Sp1-activation/REST-repression axis on GC-box promoter sites with CpG methylation as an added repressive layer.","evidence":"ChIP, luciferase reporters, and Sp1/REST knockdown/overexpression with methylation analysis in Neuro2a cells","pmids":["23250796"],"confidence":"High","gaps":["In vivo relevance of methylation-based repression not tested","Does not connect transcriptional output to synaptic phenotypes"]},{"year":2014,"claim":"Identifying an additional transcriptional regulator, Foxp2 was shown to bind the SYN1 promoter and drive expression, with miR-134-5p suppressing Foxp2 to reduce SYN1 in a vascular dementia model.","evidence":"ChIP-qPCR, dual luciferase assay, western blotting, and miR-134-5p antagomir injection in vascular dementia rats","pmids":["31545395"],"confidence":"Medium","gaps":["Single lab; reciprocal validation of the Foxp2–SYN1 axis limited","Direct functional consequence on vesicle dynamics not assessed"]},{"year":2021,"claim":"To link kinase signaling to inhibitory transmission, Cdk5 was identified as a negative regulator of SYN1 Ser-553 phosphorylation, with reduced p-SYN1(Ser-553) lowering GABA release.","evidence":"In vivo and in vitro Cdk5 inhibitor/activator studies with western blotting for p-SYN1(Ser-553) and GABA release measurements, MEK inhibitor controls","pmids":["35723394"],"confidence":"Medium","gaps":["Single lab; direct Cdk5 phosphorylation of SYN1 not reconstituted","Causal chain from Calpain-p25-Cdk5 to vesicular anchoring inferred, not directly imaged"]},{"year":2024,"claim":"Extending SP1 regulation to a pathological context, SP1 was shown to bind the SYN1 promoter and upregulate it, with SYN1 knockdown ameliorating brain injury in intracerebral hemorrhage models.","evidence":"JASPAR prediction, ChIP, luciferase reporters, si-SYN1 and SP1 overexpression in PC12 cells, and intracerebroventricular si-SYN1 in ICH rats","pmids":["39561537"],"confidence":"Medium","gaps":["Single lab; mechanism by which elevated SYN1 promotes neuronal damage not defined","Relationship to canonical presynaptic SYN1 function in damage context unclear"]},{"year":null,"claim":"How phosphorylation state at distinct sites integrates with domain-specific membrane and vesicle interactions to set the balance of synchronous versus asynchronous release in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model linking B-domain/D-domain mutations to molecular interactions","Substrate-level reconstitution of Cdk5 phosphorylation of SYN1 lacking","Integration of transcriptional regulators with synaptic output not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,2]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,5,6]}],"complexes":[],"partners":["SP1","REST","FOXP2","CDK5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P17600","full_name":"Synapsin-1","aliases":["Brain protein 4.1","Synapsin I"],"length_aa":705,"mass_kda":74.1,"function":"Neuronal phosphoprotein that coats synaptic vesicles, and binds to the cytoskeleton. Acts as a regulator of synaptic vesicles trafficking, involved in the control of neurotransmitter release at the pre-synaptic terminal (PubMed:21441247, PubMed:23406870). Also involved in the regulation of axon outgrowth and synaptogenesis (By similarity). The complex formed with NOS1 and CAPON proteins is necessary for specific nitric-oxid functions at a presynaptic level (By similarity)","subcellular_location":"Synapse; Golgi apparatus; Presynapse; Cytoplasmic vesicle, secretory vesicle, synaptic vesicle","url":"https://www.uniprot.org/uniprotkb/P17600/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SYN1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SYN1","total_profiled":1310},"omim":[{"mim_id":"611969","title":"MOB KINASE ACTIVATOR 2; MOB2","url":"https://www.omim.org/entry/611969"},{"mim_id":"610301","title":"MACOILIN 1; MACO1","url":"https://www.omim.org/entry/610301"},{"mim_id":"610197","title":"MEDIATOR COMPLEX SUBUNIT 25; MED25","url":"https://www.omim.org/entry/610197"},{"mim_id":"609917","title":"ERI1 EXORIBONUCLEASE FAMILY MEMBER 3; ERI3","url":"https://www.omim.org/entry/609917"},{"mim_id":"607649","title":"OSTEOPETROSIS-ASSOCIATED TRANSMEMBRANE PROTEIN 1; OSTM1","url":"https://www.omim.org/entry/607649"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":311.6}],"url":"https://www.proteinatlas.org/search/SYN1"},"hgnc":{"alias_symbol":[],"prev_symbol":["MRX50"]},"alphafold":{"accession":"P17600","domains":[{"cath_id":"3.30.1490.20","chopping":"248-307","consensus_level":"medium","plddt":97.9105,"start":248,"end":307}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P17600","model_url":"https://alphafold.ebi.ac.uk/files/AF-P17600-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P17600-F1-predicted_aligned_error_v6.png","plddt_mean":68.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SYN1","jax_strain_url":"https://www.jax.org/strain/search?query=SYN1"},"sequence":{"accession":"P17600","fasta_url":"https://rest.uniprot.org/uniprotkb/P17600.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P17600/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P17600"}},"corpus_meta":[{"pmid":"21441247","id":"PMC_21441247","title":"SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21441247","citation_count":190,"is_preprint":false},{"pmid":"12946570","id":"PMC_12946570","title":"Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines.","date":"2003","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/12946570","citation_count":67,"is_preprint":false},{"pmid":"23406870","id":"PMC_23406870","title":"Epileptogenic Q555X SYN1 mutant triggers imbalances in release dynamics and short-term plasticity.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23406870","citation_count":54,"is_preprint":false},{"pmid":"9914155","id":"PMC_9914155","title":"Meiotic activation of rat pachytene spermatocytes with okadaic acid: the behaviour of synaptonemal complex components SYN1/SCP1 and COR1/SCP3.","date":"1999","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/9914155","citation_count":50,"is_preprint":false},{"pmid":"23250796","id":"PMC_23250796","title":"Specificity protein 1 (Sp1)-dependent activation of the synapsin I gene (SYN1) is modulated by RE1-silencing transcription factor (REST) and 5'-cytosine-phosphoguanine (CpG) methylation.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23250796","citation_count":48,"is_preprint":false},{"pmid":"30540197","id":"PMC_30540197","title":"Gold-Catalyzed syn-1,2-Difunctionalization of Ynamides via Nitrile Activation.","date":"2018","source":"Organic letters","url":"https://pubmed.ncbi.nlm.nih.gov/30540197","citation_count":48,"is_preprint":false},{"pmid":"18331063","id":"PMC_18331063","title":"Concise asymmetric synthesis of (+)-CP-99,994 and (+)-L-733,060 via efficient construction of homochiral syn-1,2-diamines and syn-1,2-amino alcohols.","date":"2008","source":"The Journal of organic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18331063","citation_count":40,"is_preprint":false},{"pmid":"8396802","id":"PMC_8396802","title":"Role of the Na+,K+ pump in herpes simplex type 1-induced cell fusion: melittin causes specific reversion of syncytial mutants with the syn1 mutation to Syn+ (wild-type) phenotype.","date":"1993","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/8396802","citation_count":37,"is_preprint":false},{"pmid":"28973667","id":"PMC_28973667","title":"A novel SYN1 missense mutation in non-syndromic X-linked intellectual disability affects synaptic vesicle life cycle, clustering and mobility.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28973667","citation_count":36,"is_preprint":false},{"pmid":"23107381","id":"PMC_23107381","title":"Dg-Dys-Syn1 signaling in Drosophila regulates the microRNA profile.","date":"2012","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23107381","citation_count":32,"is_preprint":false},{"pmid":"9415477","id":"PMC_9415477","title":"Regional localization of two genes for nonspecific X-linked mental retardation to Xp22.3-p22.2 (MRX49) and Xp11.3-p11.21 (MRX50).","date":"1997","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9415477","citation_count":24,"is_preprint":false},{"pmid":"26139327","id":"PMC_26139327","title":"Efficient Synthesis of Differentiated syn-1,2-Diol Derivatives by Asymmetric Transfer Hydrogenation-Dynamic Kinetic Resolution of α-Alkoxy-Substituted β-Ketoesters.","date":"2015","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/26139327","citation_count":23,"is_preprint":false},{"pmid":"36568968","id":"PMC_36568968","title":"The different clinical facets of SYN1-related neurodevelopmental disorders.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36568968","citation_count":22,"is_preprint":false},{"pmid":"31545395","id":"PMC_31545395","title":"miR‑134‑5p/Foxp2/Syn1 is involved in cognitive impairment in an early vascular dementia rat model.","date":"2019","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31545395","citation_count":19,"is_preprint":false},{"pmid":"24251104","id":"PMC_24251104","title":"Porcine synapsin 1: SYN1 gene analysis and functional characterization of the promoter.","date":"2013","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/24251104","citation_count":15,"is_preprint":false},{"pmid":"37047730","id":"PMC_37047730","title":"The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37047730","citation_count":15,"is_preprint":false},{"pmid":"27685921","id":"PMC_27685921","title":"Expression profiling of RE1-silencing transcription factor (REST), REST corepressor 1 (RCOR1), and Synapsin 1 (SYN1) genes in human gliomas.","date":"2016","source":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27685921","citation_count":11,"is_preprint":false},{"pmid":"34616357","id":"PMC_34616357","title":"SYN1 Mutation Causes X-Linked Toothbrushing Epilepsy in a Chinese Family.","date":"2021","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34616357","citation_count":10,"is_preprint":false},{"pmid":"34243774","id":"PMC_34243774","title":"Familial SYN1 variants related neurodevelopmental disorders in Asian pediatric patients.","date":"2021","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/34243774","citation_count":10,"is_preprint":false},{"pmid":"29671924","id":"PMC_29671924","title":"Effects of SYN1Q555X mutation on cortical gray matter microstructure.","date":"2018","source":"Human brain mapping","url":"https://pubmed.ncbi.nlm.nih.gov/29671924","citation_count":8,"is_preprint":false},{"pmid":"35723394","id":"PMC_35723394","title":"Low p-SYN1 (Ser-553) Expression Leads to Abnormal Neurotransmitter Release of GABA Induced by Up-Regulated Cdk5 after Microwave Exposure: Insights on Protection and Treatment of Microwave-Induced Cognitive Dysfunction.","date":"2021","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35723394","citation_count":7,"is_preprint":false},{"pmid":"34830471","id":"PMC_34830471","title":"Multiparametric Evaluation of Post-MI Small Animal Models Using Metabolic ([18F]FDG) and Perfusion-Based (SYN1) Heart Viability Tracers.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34830471","citation_count":6,"is_preprint":false},{"pmid":"19028454","id":"PMC_19028454","title":"The non-neuronal syntaxin SYN-1 regulates defecation behavior and neural activity in C. elegans through interaction with the Munc13-like protein AEX-1.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19028454","citation_count":5,"is_preprint":false},{"pmid":"39618931","id":"PMC_39618931","title":"Predictive Value of SYN-1 Levels for Mortality in Sepsis Patients in the Emergency Department.","date":"2024","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/39618931","citation_count":4,"is_preprint":false},{"pmid":"39561537","id":"PMC_39561537","title":"SP1-mediated SYN1 promotes hemin-induced damage in PC12 cells in vitro and exacerbates blood-barrier disruption and brain injury after intracerebral hemorrhage in vivo.","date":"2024","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/39561537","citation_count":3,"is_preprint":false},{"pmid":"38576531","id":"PMC_38576531","title":"SYN1 variant causes X-linked neurodevelopmental disorders: a case report of variable clinical phenotypes in siblings.","date":"2024","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38576531","citation_count":3,"is_preprint":false},{"pmid":"40554312","id":"PMC_40554312","title":"Treating seizures in SYN1-related epilepsy: a systematic review.","date":"2025","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/40554312","citation_count":1,"is_preprint":false},{"pmid":"40001522","id":"PMC_40001522","title":"A Neuroprotective Peptide Modulates Retinal cAMP Response Element-Binding Protein (CREB), Synapsin I (SYN1), and Growth-Associated Protein 43 (GAP43) in Rats with Silicone Oil-Induced Ocular Hypertension.","date":"2025","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40001522","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.18.670956","title":"Epilepsy-Associated SCN2A-L1342P Mutation Drives Network Hyperexcitability and Widespread Transcriptomic Changes in Human Cortical Organoids","date":"2025-08-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.18.670956","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.14.670043","title":"Distinct and Combined Interferon-ɑ/β-receptor-1 Loss in Neurons and Astrocytes Disrupt Brain Energy Metabolism and Drive Parkinsonian Dementia","date":"2025-08-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.14.670043","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.21.634055","title":"Modeling Synaptic Maturation from Growth Cone to Synapse in Human Organoids","date":"2025-01-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.21.634055","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.02.646883","title":"Molecular Mimicry Between Epstein-Barr Virus and Human Herpesvirus-6 Proteins and Central Nervous System Proteins: Implications for T and B Cell Immunogenicity in an In Silico Study","date":"2025-04-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.02.646883","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.20.624497","title":"Effect of the daily exposure of 1.7 GHz LTE electromagnetic field in early fetal brain development using a human brain organoid model of the cerebral cortex","date":"2024-11-21","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.20.624497","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.06.26.600760","title":"The ataxia-telangiectasia disease protein ATM controls vesicular protein secretion via CHGA and microtubule dynamics via CRMP5","date":"2024-06-26","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.26.600760","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20746,"output_tokens":2245,"usd":0.047956,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9236,"output_tokens":3037,"usd":0.061053,"stage2_stop_reason":"end_turn"},"total_usd":0.109009,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"SYN1 D-domain mutations (A51G, A550T, T567A, Q555X) found in autism/epilepsy patients fail to rescue impaired synaptic vesicle pool size and trafficking in SynI knockout neurons; wild-type human SynI fully reverts the KO phenotype. The Q555X nonsense mutation additionally impairs MAPK/Erk phosphorylation of SynI and disrupts neurite outgrowth, while A550T and T567A missense mutants show impaired targeting to nerve terminals.\",\n      \"method\": \"Expression of human WT and mutant SYN1 in SynI KO neurons (lentiviral transduction), synaptic vesicle pool size/trafficking assays, phosphorylation assays, immunocytochemistry for nerve terminal targeting, neurite outgrowth assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal functional assays (vesicle trafficking, phosphorylation, targeting, neurite outgrowth) in a defined KO rescue system; multiple mutants tested\",\n      \"pmids\": [\"21441247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The epileptogenic Q555X SYN1 mutation causes a parallel decrease in the synaptic vesicle readily releasable pool in inhibitory synapses and reduced release probability in excitatory synapses, leading to reduced synchronous release. It also increases asynchronous release (especially in excitatory synapses), larger facilitation and post-tetanic potentiation in excitatory synapses, stronger depression in inhibitory synapses, and overall network hyperexcitability.\",\n      \"method\": \"Patch-clamp electrophysiology, electron microscopy, multi-electrode array recordings in SynI KO hippocampal neurons expressing WT or Q555X human SynI via lentiviral transduction\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, EM, MEA) in defined KO rescue system, mechanistic dissection of excitatory vs. inhibitory synapses\",\n      \"pmids\": [\"23406870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The SYN1 missense mutation S79W (located in the B-domain involved in recognition of highly curved membranes) causes aberrant accumulation of small clear vesicles in the soma, increased clustering of synaptic vesicles at presynaptic terminals, increased frequency of excitatory spontaneous release events, and strongly reduced mobility of synaptic vesicles when expressed in Syn1 KO hippocampal neurons.\",\n      \"method\": \"Expression of human S79W SynI in Syn1 KO hippocampal neurons, immunocytochemistry, electrophysiology (spontaneous release), live imaging of synaptic vesicle mobility\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ICC, electrophysiology, live imaging) in defined KO rescue system with mechanistic domain-level interpretation\",\n      \"pmids\": [\"28973667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SYN1 gene transcription is activated by the transcription factor Sp1 binding to conserved GC-box cis-sites in the SYN1 promoter; REST directly inhibits Sp1-mediated SYN1 transcription. Upon neuronal differentiation, decreased REST levels result in increased Sp1 stability on the promoter and increased SYN1 transcription. CpG methylation of Sp1 cis-sites provides an additional level of SYN1 transcriptional repression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), luciferase reporter assays, Sp1/REST overexpression and knockdown functional assays in Neuro2a cells, methylation analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal ChIP, reporter assays, and functional KD/OE with multiple orthogonal methods establishing mechanism of SYN1 promoter regulation\",\n      \"pmids\": [\"23250796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cdk5 is a negative regulator of SYN1 phosphorylation at Ser-553; upregulation of Cdk5 (via the Calpain-p25 pathway after microwave exposure) decreases p-SYN1(Ser-553) levels, which in turn reduces GABA release, suggesting that Ser-553 phosphorylation of SYN1 by Cdk5 controls vesicular anchoring and inhibitory neurotransmitter release.\",\n      \"method\": \"In vivo (rat) and in vitro experiments with Cdk5 inhibitors/activators, western blotting for p-SYN1 (Ser-553), GABA release measurements, MEK inhibitor controls\",\n      \"journal\": \"Current issues in molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — in vivo and in vitro inhibitor studies with functional neurotransmitter readout; single lab but two experimental systems (in vivo and in vitro)\",\n      \"pmids\": [\"35723394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SP1 binds to the SYN1 promoter region and positively regulates SYN1 expression; SP1-mediated upregulation of SYN1 contributes to hemin-induced neuronal damage (apoptosis, inflammation, oxidative stress) in PC12 cells, and SYN1 knockdown ameliorates blood-brain barrier disruption and brain injury in ICH rat models.\",\n      \"method\": \"JASPAR database prediction and validation by ChIP and luciferase reporter assays for SP1-SYN1 promoter binding; si-SYN1 and SP1 overexpression in PC12 cells; LDH, CCK-8, TUNEL, western blotting; intracerebroventricular si-SYN1 in ICH rats with neurobehavioral/brain edema/Evans blue assays\",\n      \"journal\": \"Pathology, research and practice\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — ChIP and luciferase validate SP1 binding to SYN1 promoter; functional loss-of-function in vitro and in vivo; single lab\",\n      \"pmids\": [\"39561537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Foxp2 transcription factor binds to the SYN1 promoter at -400/-600 bp upstream of the transcription start site and positively regulates SYN1 expression; miR-134-5p suppresses Foxp2 (via direct targeting of Foxp2 mRNA, validated by dual luciferase assay), leading to loss of SYN1 expression and synaptic protein reduction in a vascular dementia rat model.\",\n      \"method\": \"ChIP-qPCR for Foxp2 binding to SYN1 promoter; dual luciferase assay confirming miR-134-5p targeting of Foxp2 mRNA; western blotting; miR-134-5p antagomir intracerebroventricular injection in VD rats\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase reporter validate transcriptional mechanism; in vivo rescue experiment; single lab\",\n      \"pmids\": [\"31545395\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SYN1 encodes Synapsin I, a presynaptic phosphoprotein that regulates synaptic vesicle pool size, vesicle clustering, mobility, and both synchronous and asynchronous neurotransmitter release in excitatory and inhibitory synapses; its transcription is activated by Sp1 and Foxp2 and repressed by REST and CpG methylation; phosphorylation at Ser-553 (negatively regulated by Cdk5) controls vesicular anchoring and GABA release; and loss-of-function or missense mutations in its proline-rich D-domain or B-domain cause distinct impairments in vesicle trafficking and synaptic transmission underlying epilepsy, autism, and intellectual disability.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SYN1 encodes Synapsin I, a presynaptic phosphoprotein that governs the size, clustering, and mobility of the synaptic vesicle pool and thereby shapes both synchronous and asynchronous neurotransmitter release at excitatory and inhibitory terminals [#0, #1, #2]. Disease-associated mutations dissect these functions by domain: D-domain mutations (A51G, A550T, T567A, Q555X) found in autism/epilepsy patients fail to rescue vesicle pool size and trafficking defects in Syn1 knockout neurons, with the Q555X nonsense allele additionally abolishing MAPK/Erk phosphorylation and disrupting neurite outgrowth, and A550T/T567A impairing targeting to nerve terminals [#0]. Q555X produces a coherent network phenotype—reduced readily releasable pool and release probability driving diminished synchronous release alongside elevated asynchronous release, altered short-term plasticity, and overall hyperexcitability [#1]—while the B-domain S79W mutation, in a region recognizing curved membranes, causes somatic accumulation of clear vesicles, excess vesicle clustering, and strongly reduced vesicle mobility [#2]. Vesicular anchoring and GABA release are tuned by phosphorylation at Ser-553, which is negatively regulated by Cdk5 [#4]. SYN1 transcription is controlled by Sp1/SP1 binding to GC-box promoter sites and by Foxp2, with repression imposed by REST and CpG methylation of the Sp1 sites [#3, #5, #6]. These regulatory and trafficking activities place Synapsin I at the center of presynaptic vesicle dynamics underlying epilepsy, autism, and intellectual disability [#0, #1].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing whether patient SYN1 D-domain variants are functionally pathogenic, this work showed they fail to restore vesicle pool and trafficking in a KO rescue system where wild-type SynI fully reverts the phenotype, linking specific mutations to defined cell-biological defects.\",\n      \"evidence\": \"Lentiviral expression of human WT and mutant SYN1 in SynI KO neurons with vesicle trafficking, phosphorylation, terminal targeting, and neurite outgrowth assays\",\n      \"pmids\": [\"21441247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Does not resolve how D-domain loss mechanistically uncouples vesicle anchoring from MAPK/Erk phosphorylation\",\n        \"Targeting defect of A550T/T567A not traced to a binding partner\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"To determine how the Q555X mutation produces epilepsy, this work dissected its opposing effects on excitatory versus inhibitory synapses, establishing that imbalanced synchronous/asynchronous release generates network hyperexcitability.\",\n      \"evidence\": \"Patch-clamp electrophysiology, electron microscopy, and multi-electrode array recordings in SynI KO neurons expressing WT or Q555X SynI\",\n      \"pmids\": [\"23406870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular basis for the excitatory-vs-inhibitory divergence not defined\",\n        \"Does not establish how loss of phosphorylation translates to altered release probability\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Probing the B-domain's role in membrane curvature recognition, the S79W mutation was shown to disrupt vesicle mobility and clustering and to cause somatic vesicle accumulation, linking this domain to vesicle dispersion and trafficking distinct from D-domain defects.\",\n      \"evidence\": \"Expression of human S79W SynI in Syn1 KO neurons with immunocytochemistry, electrophysiology, and live imaging of vesicle mobility\",\n      \"pmids\": [\"28973667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct demonstration of altered curved-membrane binding by S79W not shown\",\n        \"Mechanism connecting reduced mobility to increased spontaneous excitatory events unresolved\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Addressing how SYN1 expression is controlled during neuronal differentiation, this work established a Sp1-activation/REST-repression axis on GC-box promoter sites with CpG methylation as an added repressive layer.\",\n      \"evidence\": \"ChIP, luciferase reporters, and Sp1/REST knockdown/overexpression with methylation analysis in Neuro2a cells\",\n      \"pmids\": [\"23250796\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo relevance of methylation-based repression not tested\",\n        \"Does not connect transcriptional output to synaptic phenotypes\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying an additional transcriptional regulator, Foxp2 was shown to bind the SYN1 promoter and drive expression, with miR-134-5p suppressing Foxp2 to reduce SYN1 in a vascular dementia model.\",\n      \"evidence\": \"ChIP-qPCR, dual luciferase assay, western blotting, and miR-134-5p antagomir injection in vascular dementia rats\",\n      \"pmids\": [\"31545395\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single lab; reciprocal validation of the Foxp2–SYN1 axis limited\",\n        \"Direct functional consequence on vesicle dynamics not assessed\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"To link kinase signaling to inhibitory transmission, Cdk5 was identified as a negative regulator of SYN1 Ser-553 phosphorylation, with reduced p-SYN1(Ser-553) lowering GABA release.\",\n      \"evidence\": \"In vivo and in vitro Cdk5 inhibitor/activator studies with western blotting for p-SYN1(Ser-553) and GABA release measurements, MEK inhibitor controls\",\n      \"pmids\": [\"35723394\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single lab; direct Cdk5 phosphorylation of SYN1 not reconstituted\",\n        \"Causal chain from Calpain-p25-Cdk5 to vesicular anchoring inferred, not directly imaged\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extending SP1 regulation to a pathological context, SP1 was shown to bind the SYN1 promoter and upregulate it, with SYN1 knockdown ameliorating brain injury in intracerebral hemorrhage models.\",\n      \"evidence\": \"JASPAR prediction, ChIP, luciferase reporters, si-SYN1 and SP1 overexpression in PC12 cells, and intracerebroventricular si-SYN1 in ICH rats\",\n      \"pmids\": [\"39561537\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single lab; mechanism by which elevated SYN1 promotes neuronal damage not defined\",\n        \"Relationship to canonical presynaptic SYN1 function in damage context unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How phosphorylation state at distinct sites integrates with domain-specific membrane and vesicle interactions to set the balance of synchronous versus asynchronous release in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model linking B-domain/D-domain mutations to molecular interactions\",\n        \"Substrate-level reconstitution of Cdk5 phosphorylation of SYN1 lacking\",\n        \"Integration of transcriptional regulators with synaptic output not mapped\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 5, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SP1\", \"REST\", \"FOXP2\", \"CDK5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}